Lamy Patrick 4
4 · Akero Therapeutics, Inc. · Filed Jul 2, 2025
Insider Transaction Report
Form 4
Lamy Patrick
Senior VP, Commercial Strategy
Transactions
- Award
Common Stock
2025-06-30$23.87/sh+193$4,607→ 31,891 total
Footnotes (2)
- [F1]Mr. Lamy is voluntarily reporting the acquisition of these shares on June 30, 2025 pursuant to the Akero Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(c) and Rule 16b-3(d).
- [F2]In accordance with the provisions of the Akero Therapeutics, Inc. 2019 Employee Stock Purchase Plan, these shares were purchased at 85% of the closing price of the Issuer's common stock on January 2, 2025.